• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒病免疫反应的特征:探索失调和衰竭。

Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion.

机构信息

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

出版信息

Semin Immunol. 2021 Jun;55:101508. doi: 10.1016/j.smim.2021.101508. Epub 2021 Oct 26.

DOI:10.1016/j.smim.2021.101508
PMID:34728121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8547971/
Abstract

One and half year following the occurrence of COVID-19 pandemic, significant efforts from laboratories all over the world generated a huge amount of data describing the prototypical features of immunity in the course of SARS-CoV-2 infection. In this Review, we rationalize and organize the main observations, trying to define a "core" signature of immunity in COVID-19. We identified six hallmarks describing the main alterations occurring in the early infection phase and in the course of the disease, which predispose to severe illness. The six hallmarks are dysregulated type I IFN activity, hyperinflammation, lymphopenia, lymphocyte impairment, dysregulated myeloid response, and heterogeneous adaptive immunity to SARS-CoV-2. Dysregulation and exhaustion came out as the trait d'union, connecting abnormalities affecting both innate and adaptive immunity, humoral and cellular responses.

摘要

在 COVID-19 大流行发生一年半后,来自世界各地的实验室做出了巨大努力,产生了大量数据,描述了 SARS-CoV-2 感染过程中免疫的典型特征。在这篇综述中,我们对主要观察结果进行了合理化和组织,试图确定 COVID-19 免疫的“核心”特征。我们确定了六个特征描述了在早期感染阶段和疾病过程中发生的主要改变,这些改变易导致严重疾病。这六个特征是失调的 I 型 IFN 活性、过度炎症、淋巴细胞减少、淋巴细胞功能障碍、失调的髓样细胞反应以及对 SARS-CoV-2 的异质性适应性免疫。失调和衰竭是连接影响先天免疫和适应性免疫、体液和细胞反应的异常的纽带。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/2f228092a2f2/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/519804b1758f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/e3b99fb620f3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/3d0e1b42c6b6/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/bb09115d97f3/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/2f228092a2f2/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/519804b1758f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/e3b99fb620f3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/3d0e1b42c6b6/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/bb09115d97f3/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f36/8547971/2f228092a2f2/gr5_lrg.jpg

相似文献

1
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion.新型冠状病毒病免疫反应的特征:探索失调和衰竭。
Semin Immunol. 2021 Jun;55:101508. doi: 10.1016/j.smim.2021.101508. Epub 2021 Oct 26.
2
[Immune response against the severe acute respiratory syndrome coronavirus 2].[针对严重急性呼吸综合征冠状病毒2的免疫反应]
Orv Hetil. 2022 May 15;163(20):774-787. doi: 10.1556/650.2022.32521.
3
Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.人类对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的先天性和适应性免疫反应:与获得性免疫和疫苗反应的相关性
Clin Exp Immunol. 2021 Jun;204(3):310-320. doi: 10.1111/cei.13582. Epub 2021 Mar 4.
4
The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.SARS-CoV-2 与 COVID-19 免疫病理的免疫反应——当前观点。
Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9.
5
Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.《COVID-19 中的每日病毒动力学和固有及适应性免疫反应评估:病例系列》。
mSphere. 2020 Nov 11;5(6):e00827-20. doi: 10.1128/mSphere.00827-20.
6
Hyperinflammation and Immune Response Generation in COVID-19.COVID-19 中的过度炎症反应与免疫应答产生。
Neuroimmunomodulation. 2020;27(2):80-86. doi: 10.1159/000513198. Epub 2020 Dec 18.
7
Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic.SARS-CoV-2 感染中的免疫:清晰还是神秘?在全球大流行的第三年的更广阔视角。
Arch Immunol Ther Exp (Warsz). 2023 Feb 21;71(1):7. doi: 10.1007/s00005-023-00673-0.
8
Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.雾化卡介苗接种对恒河猴 SARS-CoV-2 挑战后免疫和疾病参数的影响。
Front Immunol. 2022 Feb 9;12:801799. doi: 10.3389/fimmu.2021.801799. eCollection 2021.
9
Hallmarks of Severe COVID-19 Pathogenesis: Between Viral and Host Factors.严重 COVID-19 发病机制的特征:病毒和宿主因素之间。
Front Immunol. 2022 Jun 10;13:912336. doi: 10.3389/fimmu.2022.912336. eCollection 2022.
10
Adaptive Immune Responses and Immunity to SARS-CoV-2.适应性免疫反应与对 SARS-CoV-2 的免疫
Front Immunol. 2022 May 4;13:848582. doi: 10.3389/fimmu.2022.848582. eCollection 2022.

引用本文的文献

1
TIPE2 suppresses ferroptosis and pro-inflammatory polarization in macrophages triggered by SARS-CoV-2 spike protein.TIPE2抑制由SARS-CoV-2刺突蛋白触发的巨噬细胞铁死亡和促炎极化。
Sci Rep. 2025 Aug 18;15(1):30246. doi: 10.1038/s41598-025-14235-1.
2
Comparative analysis of neutrophil dynamics and disease in SARS-CoV-2 Delta and Omicron variants utilizing an feline model for COVID-19.利用猫科动物COVID-19模型对SARS-CoV-2 Delta和Omicron变体中的中性粒细胞动态和疾病进行比较分析。
Front Immunol. 2025 May 22;16:1547918. doi: 10.3389/fimmu.2025.1547918. eCollection 2025.
3
Pediatric autoimmune diseases in the light of COVID-19 pandemic, A retrospective observational big data study.

本文引用的文献

1
Pathological changes in the lungs and lymphatic organs of 12 COVID-19 autopsy cases.12例新冠病毒病尸检病例肺部及淋巴器官的病理变化
Natl Sci Rev. 2020 Sep 29;7(12):1868-1878. doi: 10.1093/nsr/nwaa247. eCollection 2020 Dec.
2
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.早期使用依那西普联合可溶性尿激酶型纤溶酶原激活物受体血浆水平指导 COVID-19 治疗:一项双盲、随机对照 3 期试验。
Nat Med. 2021 Oct;27(10):1752-1760. doi: 10.1038/s41591-021-01499-z. Epub 2021 Sep 3.
3
Rapid induction of antigen-specific CD4 T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.
新冠疫情背景下的儿童自身免疫性疾病:一项回顾性观察性大数据研究
J Transl Autoimmun. 2025 Mar 6;10:100281. doi: 10.1016/j.jtauto.2025.100281. eCollection 2025 Jun.
4
Lower Plasma IL-32 Levels Linked to Better Survival in Sepsis.血浆白细胞介素-32水平较低与脓毒症患者更好的生存率相关。
Biomedicines. 2025 Mar 19;13(3):750. doi: 10.3390/biomedicines13030750.
5
Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability.流感与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在老年和幼年人群中合并感染的发病机制:解读免疫脆弱性的不祥故事
Adv Biotechnol (Singap). 2025 Jan 21;3(1):5. doi: 10.1007/s44307-025-00057-9.
6
BALB/c mice challenged with SARS-CoV-2 B.1.351 β variant cause pathophysiological and neurological changes within the lungs and brains.BALB/c 小鼠感染 SARS-CoV-2 B.1.351 β 变体后,肺部和脑部会发生病理生理学和神经学变化。
J Gen Virol. 2024 Oct;105(10). doi: 10.1099/jgv.0.002039.
7
Advancing insights in critical COVID-19: unraveling lymphopenia through propensity score matching - Findings from the Multicenter LYMPH-COVID Study.新冠肺炎关键进展:通过倾向评分匹配揭示淋巴细胞减少症——多中心LYMPH-COVID研究的结果
Crit Care Sci. 2024 Sep 27;36:e20240236en. doi: 10.62675/2965-2774.20240236-en. eCollection 2024.
8
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.从检测到防护:抗体及其在诊断和对抗新冠病毒中的关键作用。
Vaccines (Basel). 2024 Apr 25;12(5):459. doi: 10.3390/vaccines12050459.
9
Serum Adiponectin Predicts COVID-19 Severity.血清脂联素可预测新冠病毒疾病的严重程度。
Biomedicines. 2024 May 9;12(5):1043. doi: 10.3390/biomedicines12051043.
10
High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4 and CD8 memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients.高频率的α型普通感冒冠状病毒/SARS-CoV-2 交叉反应性功能性 CD4 和 CD8 记忆 T 细胞与未接种疫苗的 COVID-19 患者免受有症状和致命 SARS-CoV-2 感染有关。
Front Immunol. 2024 Mar 28;15:1343716. doi: 10.3389/fimmu.2024.1343716. eCollection 2024.
快速诱导抗原特异性 CD4 T 细胞与对 SARS-CoV-2 mRNA 疫苗接种的协调体液和细胞免疫有关。
Immunity. 2021 Sep 14;54(9):2133-2142.e3. doi: 10.1016/j.immuni.2021.08.001. Epub 2021 Aug 13.
4
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis.阿那白滞素对新型冠状病毒肺炎患者死亡率的影响:一项系统评价和患者水平的荟萃分析。
Lancet Rheumatol. 2021 Oct;3(10):e690-e697. doi: 10.1016/S2665-9913(21)00216-2. Epub 2021 Aug 9.
5
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.SARS-CoV-2 特异性 T 细胞应答在儿童中较低,并随着年龄和感染后时间的增加而增加。
Nat Commun. 2021 Jul 29;12(1):4678. doi: 10.1038/s41467-021-24938-4.
6
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.卡那奴单抗对比安慰剂对住院严重 COVID-19 患者免于有创机械通气的生存影响:一项随机临床试验。
JAMA. 2021 Jul 20;326(3):230-239. doi: 10.1001/jama.2021.9508.
7
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.无论住院时新冠病情严重程度如何,新冠病毒2型特异性体液免疫和细胞免疫均可持续9个月。
Clin Transl Immunology. 2021 Jul 5;10(7):e1306. doi: 10.1002/cti2.1306. eCollection 2021.
8
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.纵向分析显示,SARS-CoV-2 感染后具有持久的抗体反应和记忆 B 细胞和 T 细胞,可产生持久和广泛的免疫记忆。
Cell Rep Med. 2021 Jul 20;2(7):100354. doi: 10.1016/j.xcrm.2021.100354. Epub 2021 Jul 3.
9
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.抗体对 SARS-CoV-2 的反应揭示了非结构/辅助蛋白和结构蛋白之间的显著差异。
Cell Rep. 2021 Jul 13;36(2):109391. doi: 10.1016/j.celrep.2021.109391. Epub 2021 Jun 26.
10
Impact of SARS-CoV-2 variants on the total CD4 and CD8 T cell reactivity in infected or vaccinated individuals.新冠病毒变异株对感染或接种个体中总 CD4 和 CD8 T 细胞反应性的影响。
Cell Rep Med. 2021 Jul 20;2(7):100355. doi: 10.1016/j.xcrm.2021.100355. Epub 2021 Jul 2.